🇺🇸 FDA

Company profile · Sponsor

GT

GT Biopharma

GTBP · NYSE biotech SAN FRANCISCO, CA, USA
Pipeline
8
Drugs
0
Patents
1

Quick answer

GT (GTBP) is a biotech company. headquartered in SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker GTBP
Exchange NYSE
Company type biotech
Headquarters SAN FRANCISCO, CA, USA
SEC CIK 0000109657

Pipeline (8)

Search pipeline →

  1. Stereotactic Radiation Therapy

    GT

    Brain Metastases

    phase 3 other active

    1 trial

  2. Temozolomide

    GT

    Glioblastoma

    phase 3 small molecule active

    1 trial

  3. Cesium-131 brachytherapy

    GT

    Recurrent Brain Metastases

    phase 2 other active

    1 trial

  4. GTB-3550 TriKE® Phase I

    GT

    High-risk Myelodysplastic Syndromes

    phase 2 small molecule terminated

    1 trial

  5. GTB-5550

    GT

    Tri-specific Killer Engager

    phase 1 small molecule active

    1 trial

  6. Stereotactic Radiation Therapy

    GT

    Glioblastoma

    approved other terminated

    1 trial

  7. Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

    GT

    Glioblastoma

    approved other active

    1 trial

  8. Semaglutide

    GT

    Obesity (Disorder)

    small molecule active

    1 trial

Patents (1)

Search patents →

  1. US 10071150

    Immunity enhancing therapeutic vaccine for HPV and related diseases

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is GT?

GT (GTBP) is a biotech company. headquartered in SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does GT sponsor?

We track 8 ClinicalTrials.gov-linked programs for GT, including Stereotactic Radiation Therapy and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does GT company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.